Mohammad Mehraban, PhD, MS
Postdoctoral Scholar
Pathology
School of Medicine

Publications (9)

Top publication keywords:
LactoglobulinsMicroRNAsHeterocyclic Compounds, 3-RingCaco-2 CellsKanamycinDrug CarriersDrug Delivery SystemsSucrase-Isomaltase ComplexCiprofloxacinHydrophobic and Hydrophilic InteractionsGene Expression Regulation, EnzymologicGlycoside Hydrolase InhibitorsPyrimidinonesDown-Regulationalpha-Glucosidases

• Predicting metabolic dysfunction-associated steatotic liver disease risk using patient-derived induced pluripotent stem cells.
  Stem cells translational medicine 2026 Qin Y, Chhetri P, Theusch E, Lim G, Teker SS, Kuang YL, Aziziraftar SK, Mehraban MH, Munoz-Howell A, Saxena V, Le Guillou D, Mattis AN, Maher JJ, Medina MW
• Predicting Metabolic Dysfunction Associated Steatotic Liver Disease Risk Using Patient-Derived Induced Pluripotent Stem Cells.
  bioRxiv : the preprint server for biology 2025 Qin Y, Chhetri P, Theusch E, Lim G, Teker S, Kuang YL, Aziziraftar SK, Mehraban MH, Munoz-Howell A, Saxena V, Le Guillou D, Mattis AN, Maher JJ, Medina MW
• Clinical and experimental bacteriophage studies: Recommendations for possible approaches for standing against SARS-CoV-2.
  Microbial pathogenesis 2022 Shahin K, Zhang L, Mehraban MH, Collard JM, Hedayatkhah A, Mansoorianfar M, Soleimani-Delfan A, Wang R
• MiR-26a and miR-26b downregulate the expression of sucrase-isomaltase enzyme: A new chapter in diabetes treatment.
  Biochemical and biophysical research communications 2019 Mehraban MH, Motovali-Bashi M, Ghasemi Y
• Maltase-glucoamylase inhibition potency and cytotoxicity of pyrimidine-fused compounds: An in silico and in vitro approach.
  Computational biology and chemistry 2019 Mehraban MH, Mansourian M, Ahrari S, HajiEbrahimi A, Odooli S, Motovali-Bashi M, Yousefi R, Ghasemi Y

Show all (4 more) Hide

• The interaction of beta-lactoglobulin with ciprofloxacin and kanamycin; a spectroscopic and molecular modeling approach.
  Journal of biomolecular structure & dynamics 2016 Mehraban MH, Odooli S, Yousefi R, Roghanian R, Motovali-Bashi M, Moosavi-Movahedi AA, Ghasemi Y
• Binding study of novel anti-diabetic pyrimidine fused heterocycles to β-lactoglobulin as a carrier protein.
  Colloids and surfaces. B, Biointerfaces 2013 Mehraban MH, Yousefi R, Taheri-Kafrani A, Panahi F, Khalafi-Nezhad A
• Synthesis of new pyrimidine-fused derivatives as potent and selective antidiabetic α-glucosidase inhibitors.
  Carbohydrate research 2013 Panahi F, Yousefi R, Mehraban MH, Khalafi-Nezhad A
• Pyrimidine-fused heterocycle derivatives as a novel class of inhibitors for α-glucosidase.
  Journal of enzyme inhibition and medicinal chemistry 2012 Yousefi R, Alavian-Mehr MM, Mokhtari F, Panahi F, Mehraban MH, Khalafi-Nezhad A